Skip to main content

Advertisement

SpringerLink
Log in

Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Although lymphadenectomy is currently accepted as most accurate and reliable staging procedure for lymph node metastases, its therapeutic benefit in renal cell carcinoma (RCC) still remains controversial. Although the new, targeted therapy paradigms have changed the treatment of patients with advanced RCC and offer prolonged survival, cure is extremely uncommon in the absence of surgical resections. In this paper, the current role of metastasectomy is reviewed. Review the available literature concerning the role of retroperitoneal lymph node dissection and metastasectomy in outcome of oligometastatic RCC. A PubMed search was conducted to identify original articles, review articles, and editorials addressing the role of retroperitoneal lymph node dissection and metastasectomy in outcome of oligometastatic RCC. Keywords included renal tumors, renal cell cancer, kidney cancer, lymphadenectomy, metastasectomy, and oligometastases. While there is no randomized study available, recent large observational studies have better defined the prognosis of patients with metastatic RCC with or without metastasectomy and RPLND. To date, the available evidence suggests that RPLND and metastasectomy may be beneficial when technically feasible in patients with locally advanced (unfavorable clinical and pathologic characteristics) and oligometastatic disease. A proportion of patients will achieve long-term survival with aggressive surgical resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10. https://doi.org/10.1200/JCO.1995.13.1.8

    Article  CAS  PubMed  Google Scholar 

  2. Weichselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8(6):378–382. https://doi.org/10.1038/nrclinonc.2011.44

    Article  CAS  PubMed  Google Scholar 

  3. Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:571–573

    Article  Google Scholar 

  4. Chow WH, Devesa SS, Warren JL (1999) The rising incidence of renal cell carcinoma in the United States of America. JAMA 282:1629–1312

    Google Scholar 

  5. Motzer RJ, Bander NH, Nanus DM (1996) Renal cell carcinoma. N. Engl. J. Med 335(12):865–875

    Article  CAS  PubMed  Google Scholar 

  6. Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh QD, Briganti A, Tian Z, Schmitges J, Graefen M, Perrotte P, Menon M, Montorsi F, Karakiewicz PI (2012) Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 23(4):973–980. https://doi.org/10.1093/annonc/mdr362

    Article  CAS  PubMed  Google Scholar 

  7. Barney JD, Churchill EJ (1939) Adenocarcinoma of the kidney with metastasis to the lung. J Urol 42(3):269–276. https://doi.org/10.1016/S0022-5347(17)71516-9

    Article  Google Scholar 

  8. Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H (2002) Long term results after pulmonary resection of renal cell carcinoma metastasis. Ann Thorac Surg 73(4):1082–1087. https://doi.org/10.1016/S0003-4975(01)03602-5

    Article  PubMed  Google Scholar 

  9. Friedel G, Hürtgen M, Penzenstadler M, Kyriss T, Toomes H (1999) Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res 19:1593–1596

  10. Pfannschmidt J, Hoffmann H, Krysa S, Trainer C, Dienemann H (2002) Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 74(5):1653–1657. https://doi.org/10.1016/S0003-4975(02)03803-1

    Article  PubMed  Google Scholar 

  11. Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF, Pairolero PC (1994) Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 57(2):339–344. https://doi.org/10.1016/0003-4975(94)90994-6

    Article  CAS  PubMed  Google Scholar 

  12. Zekri J, Ahmed N, Coleman RE, Hancock BW (2001) The skeletal metastatic complications of renal cell carcinoma. Int. J. Oncol 19(2):379–382

    CAS  PubMed  Google Scholar 

  13. Jung ST, Ghert MA, Harrelson JM, Scully SP (2003) Treatment of osseous metastasis in patients with renal cell carcinoma. Clin Orthop Relat Res 409:223–231. https://doi.org/10.1097/01.blo.0000059580.08469.3e

    Article  Google Scholar 

  14. Alves A, Adam R, Majno P, Delvart V, Azoulay D, Castaong D, Bismuth H (2003) Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol 10(6):705–710. https://doi.org/10.1245/ASO.2003.07.024

    Article  CAS  PubMed  Google Scholar 

  15. Suppiah R, Shaheen PE, Elson P et al (2006) Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 107(8):1793–1800

    Article  PubMed  Google Scholar 

  16. Ruys AT, Tanis PJ, Iris ND, van Duijvendijk P, Verhoef C, Porte RJ, van Gulik TM (2011) Surgical treatment of renal cell cancer liver metastasis: a population based study. Ann Surg Oncol 18(7):1932–1938. https://doi.org/10.1245/s10434-010-1526-x

    Article  PubMed  PubMed Central  Google Scholar 

  17. McKay RR, Kroeger N, Xie W, Lee JL, Knox JJ, Bjarnason GA, MacKenzie MJ, Wood L, Srinivas S, Vaishampayan UN, Rha SY, Pal SK, Donskov F, Tantravahi SK, Rini BI, Heng DY, Choueiri TK (2014) Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy. Eur Urol 65(3):577–584. https://doi.org/10.1016/j.eururo.2013.08.012

    Article  PubMed  Google Scholar 

  18. Bennington JL (1973) Proceedings: cancer of the kidney-etiology, epidemiology and pathology. Cancer 32(5):1017–1029. https://doi.org/10.1002/1097-0142(197311)32:5<1017::AID-CNCR2820320501>3.0.CO;2-Z

    Article  CAS  PubMed  Google Scholar 

  19. Ballarin R, Spaggiari M, Cautero N, Deruvo N, Montalti R, Longo C et al (2011) Pancreatic metastasis from renal cell carcinoma: the state of the art. World J Gastroenterol 17(43):4747–4756. https://doi.org/10.3748/wjg.v17.i43.4747

    Article  PubMed  PubMed Central  Google Scholar 

  20. Yuasa T, Inoshita N, Saiura A, Yamamoto S, Urakami S, Masuda H, Fujii Y, Fukui I, Ishikawa Y, Yonese J (2015) Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer 15(1):46. https://doi.org/10.1186/s12885-015-1050-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Bianchi M, Sun M, Jeldres C (2012) Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 23(4):973–980. https://doi.org/10.1093/annonc/mdr362

    Article  CAS  PubMed  Google Scholar 

  22. Tsui KH, Shvarts O, Barbaric Z (2000) Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. J Urol 163(2):437–441. https://doi.org/10.1016/S0022-5347(05)67895-0

    Article  CAS  PubMed  Google Scholar 

  23. Kuczyk M, Munch T, Machtens S (2002) The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience. BJU Int 89(6):517–522. https://doi.org/10.1046/j.1464-410X.2002.02671.x

    Article  CAS  PubMed  Google Scholar 

  24. Saitoh H, Nakayama M, Nakamura K, Satoh T (1982) Distant metastasis of renal adenocarcinoma in nephrectomized cases. J Urol 127(6):1092–1095. https://doi.org/10.1016/S0022-5347(17)54243-3

    Article  CAS  PubMed  Google Scholar 

  25. Mortensen H (1948) Transthoracic nephrectomy. J Urol 60(6):855–858. https://doi.org/10.1016/S0022-5347(17)69315-7

    Article  CAS  PubMed  Google Scholar 

  26. Breau RH, Allmer C, Lohse CM, Cheville JC, Leibovich BC, Blute ML (2011) Lymph node dissection at the time of radical nephrectomy for high risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol 59(1):18–23. Crispen PL

  27. Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101(3):297–301. https://doi.org/10.1016/S0022-5347(17)62331-0

    Article  CAS  PubMed  Google Scholar 

  28. Parker AE (1935) Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatic’s of the genito-urinary system. Am J Anat 56(3):409–443. https://doi.org/10.1002/aja.1000560305

    Article  Google Scholar 

  29. Herrlinger A, Schrott KM, Schott G, Sigel A (1991) What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. J Urol 146(5):1224–1227. https://doi.org/10.1016/S0022-5347(17)38052-7

    Article  CAS  PubMed  Google Scholar 

  30. Whitson JM, Harris CR, Reese AC et al (2011) Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastasis. J Urol 185:1615–1620

    Article  PubMed  Google Scholar 

  31. Delacroix SE Jr, Chapin BF, Chen JJ et al (2011) Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma? J Urol 186:1236–1241

    Article  PubMed  Google Scholar 

  32. Blute ML, Leibovich BC, Cheville JC et al A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 172(2):465–469

  33. Terrone C, Guercio S, De Luca S et al The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 91(1):37–40

  34. Blom JHM, van Poppel H, Marechal JM et al (2009) Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 55(1):28–34. https://doi.org/10.1016/j.eururo.2008.09.052

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Uro-Oncology, HCG Bangalore Institute of Oncology, Bangalore, India

    H. Nagaraja, N. Srivatsa, S. Hemalatha, S. Shweta & S. K. Raghunath

Authors
  1. H. Nagaraja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Srivatsa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Hemalatha
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Shweta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. K. Raghunath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. K. Raghunath.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nagaraja, H., Srivatsa, N., Hemalatha, S. et al. Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma. Indian J Surg Oncol 9, 105–109 (2018). https://doi.org/10.1007/s13193-018-0722-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-018-0722-1

Keywords

Search

Navigation